Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Epizyme Inc (NASDAQ:EPZM)

9.20
Delayed Data
As of Jun 27
 -0.65 / -6.60%
Today’s Change
8.27
Today|||52-Week Range
25.25
-42.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-702.0K-3.5M-55.0M-132.4M
 
 
 
 
 
Depreciation847.0K703.0K742.0K1.4M
 
 
 
 
 
Total Other Cash Flow724.0K2.8M6.9M49.9M
 
 
 
 
 
Funds From Operations869.0K39.0K-47.4M-81.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-43.3M53.8M-12.0M-8.2M
 
 
 
 
 
Net Cash Flow - Operating Activities44.2M-53.7M-35.4M-72.9M
 
 
 
 
 
 
InvestingCapital Expenditures-1.5M-630.0K-2.2M-183.0K
 
 
 
 
 
Other Investing - Uses0.000.000.00-40.0M
 
 
Other Investing - Sources37.0K0.000.000.00
 
 
Net Cash Flow Investing-1.4M-630.0K-2.2M-40.2M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00-441.0K
 
 
Net Proceeds Stock Sale21.9M277.0K103.8M131.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.0082.5M286.0K0.00
 
 
 
Other Uses - Financing0.002.8M0.000.00
 
 
Net Cash Flow - Financing21.9M79.9M104.1M131.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.00----
 
Net Change In Cash64.6M25.6M66.5M18.2M